SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001571049-15-000947
Filing Date
2015-02-10
Accepted
2015-02-10 16:23:32
Documents
1
Group Members
ADVANCED TECHNOLOGY VENTURES VI, L.P.ADVANCED TECHNOLOGY VENTURES VII (B), L.P.ADVANCED TECHNOLOGY VENTURES VII(C), L.P.ATV ALLIANCE 2003, L.P.ATV ALLIANCE ASSOCIATES, L.L.C.ATV ASSOCIATES VI, L.L.C.ATV ASSOCIATES VII, L.L.C.ATV ENTREPRENEURS VI, L.P.ATV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 1) t81336_sc13ga.htm SC 13G/A 400242
  Complete submission text file 0001571049-15-000947.txt   401969
Mailing Address
Business Address 281 WINTER ST SUITE 350 WALTHAM MA 02451 7812900707
ADVANCED TECHNOLOGY VENTURES VII LP (Filed by) CIK: 0001138942 (see all company filings)

Type: SC 13G/A

Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87623 | Film No.: 15594177
SIC: 2834 Pharmaceutical Preparations